Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Disney’s domestic parks fueled Q2 strength: International results lagged, but a capital-light Abu Dhabi expansion points to future opportunity.

Disney’s streaming bundle is driving subscriber gains and lower churn: But fiscal caution and ad headwinds may limit future momentum.

A growing majority worry AI will distort news, cut jobs, and mislead audiences—pressuring media brands to prioritize transparency and human oversight in AI use.

Insights from IAB NewFronts: Streaming and AI innovation are transforming marketing—but in a period of rapid change and economic unrest, adaptation is key.

A move to a public benefit structure could drastically cut Microsoft’s profits, signaling a power shift in the alliance that has fueled Azure’s recent growth.

Many workers embrace genAI tools like ChatGPT in secret to gain an edge, raising concerns around job insecurity, workplace transparency, and growing cybersecurity risks.

YouTube’s 2.50 billion monthly active users worldwide outnumber those on all other digital platforms, according to our 2024 forecasts and Spotify data.

Hugo Boss is adjusting to the macro landscape on the fly: The German fashion house is rerouting China-made goods to other markets and stockpiling in the US to blunt the impact of tariffs.

But its megadeal with Worldpay and FIS will transform its business and expand its revenue opportunities

The agency wants to rework the rules to address banks' concerns. We look at what it would mean for open banking adoption in the US.

US consumers will spend $3.2 billion on flowers this Mother’s Day: While NRF’s forecast is flat YoY, florists face tighter margins as tariffs drive up costs.

Google’s AI Max product promises one-click boost to ad performance: AI integration will allow for advanced query matching, but a Chrome sell-off looms large.

Shein and Temu pull back US digital ad spending, shift to Europe: The change shows how geopolitical tensions trickle down to business operations.

This launch could revolutionize PayPal’s in-store ambitions—and provide real competition for Apple Pay

Tariffs make content creation a riskier gig: If brand deals dry up, creators could seek more traditional career paths.

Ford expects tariffs to take a $1.5 billion bite out of profits: That’s in spite of its sizable US manufacturing base, which bodes ill for its globalized competitors.

Food delivery platforms are in expansion mode: DoorDash, Uber, Instacart, and Wonder are turning to acquisitions and new markets to maintain their momentum.

Trump asks regulators to make it easier to build US drug manufacturing sites: Drugmakers should wait for the precise tariff rate on the sector—set to come within two weeks—before investing in more domestic infrastructure.

Function Health acquires Ezra, drops price of full-body MRI scan: Whole-body MRI screenings are out of most people’s price range. Marketers and influencers fueling the preventative wellness trend should also remind consumers of lower-cost, more accessible services.

Americans aren’t confident that federal health agencies ensure safe and effective drugs: Pharma marketers need to lean on individual physicians and local health agencies to help consumers understand the safety and effectiveness of prescription drugs and vaccines.